About Aleva Neuro
Aleva Neuro is a company based in Lausanne (Switzerland) founded in 2008 by Claudio Pollo.. Aleva Neuro has raised $57.05 million across 8 funding rounds from investors including The Michael J. Fox Foundation, CIP Merchant Capital and Greatbatch. Aleva Neuro offers products and services including directSTIM™ DBS System. Aleva Neuro operates in a competitive market with competitors including Openwater, Rune Labs, PhotoPharmics, PD Neurotechnology and Cala Health, among others.
- Headquarter Lausanne, Switzerland
- Founders Claudio Pollo
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aleva Neurotherapeutics Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$57.05 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
The Michael J. Fox Foundation
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aleva Neuro
Aleva Neuro offers a comprehensive portfolio of products and services, including directSTIM™ DBS System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides directional stimulation for treating Parkinson's and essential tremor.
Unlock access to complete
Unlock access to complete
Funding Insights of Aleva Neuro
Aleva Neuro has successfully raised a total of $57.05M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
- First Round First Round
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series E - Aleva Neuro | Valuation | CIP Merchant Capital |
|
| Dec, 2019 | Amount | Series E - Aleva Neuro | Valuation |
investors |
|
| Oct, 2017 | Amount | Series D - Aleva Neuro | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aleva Neuro
Aleva Neuro has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include The Michael J. Fox Foundation, CIP Merchant Capital and Greatbatch. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aleva Neuro
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aleva Neuro
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aleva Neuro Comparisons
Competitors of Aleva Neuro
Aleva Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Openwater, Rune Labs, PhotoPharmics, PD Neurotechnology and Cala Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of imaging technologies for medical diagnosis and treatments
|
|
| domain | founded_year | HQ Location |
Therapy management is enabled via a neuromodulation data platform.
|
|
| domain | founded_year | HQ Location |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| domain | founded_year | HQ Location |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| domain | founded_year | HQ Location |
Wearable neuromodulation devices for essential tremor relief are developed.
|
|
| domain | founded_year | HQ Location |
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aleva Neuro
Frequently Asked Questions about Aleva Neuro
When was Aleva Neuro founded?
Aleva Neuro was founded in 2008.
Where is Aleva Neuro located?
Aleva Neuro is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Is Aleva Neuro a funded company?
Aleva Neuro is a funded company, having raised a total of $57.05M across 8 funding rounds to date. The company's 1st funding round was a Series D of $13M, raised on Jun 01, 2008.
What does Aleva Neuro do?
Aleva Neurotherapeutics was founded in 2008 in Lausanne, Switzerland, within the neurostimulation sector. A MEMS-based neurostimulation platform is utilized to create micro deep brain stimulation technology, targeting conditions like Parkinsons disease and essential tremor. Implantable systems such as the directSTIM DBS System are produced, alongside diagnostic tools including the spiderSTIM DBS Diagnostic System, to support therapies for neurological disorders.
Who are the top competitors of Aleva Neuro?
Aleva Neuro's top competitors include Rune Labs, Openwater and PhotoPharmics.
What products or services does Aleva Neuro offer?
Aleva Neuro offers directSTIM™ DBS System.
Who are Aleva Neuro's investors?
Aleva Neuro has 9 investors. Key investors include The Michael J. Fox Foundation, CIP Merchant Capital, Greatbatch, BioMedPartners, and BB Biotech Ventures.
What is Aleva Neuro's valuation?
The valuation of Aleva Neuro is $54.2M as of Dec 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.